Test Code SLFA Cryptococcus Antigen Screen with Titer, Serum
Useful For
Aiding in the diagnosis of cryptococcosis
This test should not be used as a test of cure or to guide treatment decisions.
This test should not be used as a screening procedure for the general populations.
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| SLFAT | Cryptococcus Ag Titer, LFA, S | Yes | No |
Testing Algorithm
If the screen result is positive, the Cryptococcus titer will be performed at an additional charge.
Reporting Name
Cryptococcus Ag Screen w/Titer, SSpecimen Type
SerumSpecimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL Serum
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
Serum: 0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 14 days |
| Frozen | 14 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | Reject |
Clinical Information
Cryptococcosis is an invasive fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii. C neoformans has been isolated from several environmental sources, especially weathered pigeon droppings. Historically, C gattii was associated with tropical and subtropical regions. More recently, it has been recognized as endemic in British Columbia and the Pacific Northwestern US and is associated with several different tree species.
Infection is usually acquired via the pulmonary route. Patients are often unaware of any exposure history. Approximately half of the patients with symptomatic disease have a predisposing immunosuppressive condition such as AIDS, steroid therapy, lymphoma, or sarcoidosis. Symptoms may include fever, headache, dizziness, ataxia, somnolence, and cough. While the majority of C neoformans infections occur in immunocompromised patient populations, C gattii is has a greater predilection for infection of healthy individuals.(1,2)
In addition to the lungs, cryptococcal infections often involve the central nervous system (CNS), especially in patients with HIV infection. Mortality among patients with CNS cryptococcosis may approach 25% despite antifungal therapy. Untreated CNS cryptococcosis is invariably fatal. Disseminated disease may involve any organ system and usually occurs in immunosuppressed individuals.
Reference Values
Negative
Report Available
Same day/1 to 2 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
87899
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| SLFA | Cryptococcus Ag Screen w/Titer, S | 29903-2 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 62075 | Cryptococcus Ag Screen w/Titer, S | 29903-2 |
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.Method Name
Lateral Flow Assay (LFA)